Showing codes J8522 (Capecitabine, oral, 50 mg) — J9025 (Injection, azacitidine, 1 mg)

J8522 - Capecitabine, oral, 50 mg
Long description: Capecitabine, oral, 50 mg
Code added date: 20241001.
Code effective date: 20241001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J8530 - Cyclophosphamide oral 25 mg
Long description: Cyclophosphamide; oral, 25 mg
Code added date: 19950101.
Code effective date: 19970831.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J8540 - Oral dexamethasone
Long description: Dexamethasone, oral, 0.25 mg
Code added date: 20060101.
Code effective date: 20060101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J8541 - Oral, hemady, 0.25 mg
Long description: Dexamethasone (hemady), oral, 0.25 mg
Code added date: 20241001.
Code effective date: 20241001.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J8560 - Etoposide oral 50 mg
Long description: Etoposide; oral, 50 mg
Code added date: 19950101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J8561 - Oral everolimus
Long description: Everolimus, oral, 0.25 mg
Code added date: 20120101.
Code effective date: 20130101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J8562 - Oral fludarabine phosphate
Long description: Fludarabine phosphate, oral, 10 mg
Code added date: 20110101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J8565 - Gefitinib oral
Long description: Gefitinib, oral, 250 mg
Code added date: 20050101.
Code effective date: 20150101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J8597 - Antiemetic drug oral nos
Long description: Antiemetic drug, oral, not otherwise specified
Code added date: 20060101.
Code effective date: 20060101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J8600 - Melphalan oral 2 mg
Long description: Melphalan; oral, 2 mg
Code added date: 19950101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J8610 - Methotrexate oral 2.5 mg
Long description: Methotrexate; oral, 2.5 mg
Code added date: 19950101.
Code effective date: 19970831.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J8611 - Oral methotrexate (jylamvo)
Long description: Methotrexate (jylamvo), oral, 2.5 mg
Code added date: 20240701.
Code effective date: 20240701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J8612 - Oral methotrexate (xatmep)
Long description: Methotrexate (xatmep), oral, 2.5 mg
Code added date: 20240701.
Code effective date: 20240701.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J8650 - Nabilone oral
Long description: Nabilone, oral, 1 mg
Code added date: 20070101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J8655 - Oral netupitant, palonosetro
Long description: Netupitant 300 mg and palonosetron 0.5 mg, oral
Code added date: 20160101.
Code effective date: 20190101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J8670 - Rolapitant, oral, 1mg
Long description: Rolapitant, oral, 1 mg
Code added date: 20170101.
Code effective date: 20170101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J8700 - Temozolomide
Long description: Temozolomide, oral, 5 mg
Code added date: 20010101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J8705 - Topotecan oral
Long description: Topotecan, oral, 0.25 mg
Code added date: 20090101.
Code effective date: 20240101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J8999 - Oral prescription drug chemo
Long description: Prescription drug, oral, chemotherapeutic, nos
Code added date: 19950101.
Code effective date: 19970101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9000 - Doxorubicin hcl injection
Long description: Injection, doxorubicin hydrochloride, 10 mg
Code added date: 19840101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9001 - Doxorubicin hcl liposome inj
Long description: Injection, doxorubicin hydrochloride, all lipid formulations, 10 mg
Code added date: 20000101.
Code effective date: 20130101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

J9002 - Doxil injection
Long description: Injection, doxorubicin hydrochloride, liposomal, doxil, 10 mg
Code added date: 20130101.
Code effective date: 20140101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

J9010 - Alemtuzumab injection
Long description: Injection, alemtuzumab, 10 mg
Code added date: 20030101.
Code effective date: 20160101.
Pricing Indicator Code(s): 00 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: I (A code denoting Medicare coverage status).
HTML    PDF

J9015 - Aldesleukin injection
Long description: Injection, aldesleukin, per single use vial
Code added date: 19960101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9017 - Arsenic trioxide injection
Long description: Injection, arsenic trioxide, 1 mg
Code added date: 20020101.
Code effective date: 20090101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9019 - Erwinaze injection
Long description: Injection, asparaginase (erwinaze), 1,000 iu
Code added date: 20130101.
Code effective date: 20130101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9020 - Asparaginase, nos
Long description: Injection, asparaginase, not otherwise specified, 10,000 units
Code added date: 19840101.
Code effective date: 20160101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: D (A code denoting Medicare coverage status).
HTML    PDF

J9021 - Inj, aspara, rylaze, 0.1 mg
Long description: Injection, asparaginase, recombinant, (rylaze), 0.1 mg
Code added date: 20220101.
Code effective date: 20220101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9022 - Inj, atezolizumab,10 mg
Long description: Injection, atezolizumab, 10 mg
Code added date: 20180101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9023 - Injection, avelumab, 10 mg
Long description: Injection, avelumab, 10 mg
Code added date: 20180101.
Code effective date: 20180101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF

J9025 - Azacitidine injection
Long description: Injection, azacitidine, 1 mg
Code added date: 20060101.
Code effective date: 20230101.
Pricing Indicator Code(s): 51 ; (Codes used to identify the appropriate methodology for developing unique pricing amounts under part B. A procedure may have one to four pricing codes.)
Coverage Code: C (A code denoting Medicare coverage status).
HTML    PDF